SAN FRANCISCO (December 21, 2010) – Morrison & Foerster recently secured a jury verdict for ICU Medical, Inc. in a patent infringement case against RyMed Technologies, Inc. On December 17, 2010, an eight-person jury in the U.S. District Court of Delaware found that RyMed’s InVision Plus I.V. connector infringes two patents owned by ICU. The jury also found that ICU’s patents are valid.
“We are pleased that the jury confirmed the validity of ICU's patents and found infringement of those patents by RyMed," said Morrison & Foerster partner James Bennett, who was lead attorney for ICU in this case.
ICU develops, manufactures, and sells innovative medical technologies used in vascular therapy, oncology, and critical care applications. In July 2007, ICU filed a complaint against RyMed alleging that the InVision Plus I.V. connector infringes certain patents owned by ICU relating to ICU’s needle-free I.V. connector technology.
Along with Mr. Bennett, the Morrison & Foerster team included partners Karen Hagberg, Rory Radding, and Kim Van Voorhis, as well as associates Katherine Nolan Stevaux, Daniel Zlatnik, and Diana Luo.